Rockwell Medical, Inc.
RMTI
$1.18
$0.021.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.52% | -100.40% | -145.43% | 385.13% | 119.82% |
| Total Depreciation and Amortization | 4.45% | -0.74% | 0.00% | -1.09% | 0.73% |
| Total Amortization of Deferred Charges | 0.00% | -1.12% | 1.14% | 193.33% | -86.30% |
| Total Other Non-Cash Items | -21.51% | 15.75% | -13.68% | 60.79% | -7.92% |
| Change in Net Operating Assets | 147.91% | -74,860.00% | -99.40% | 544.44% | 91.34% |
| Cash from Operations | 152.88% | -503.12% | -79.77% | 196.46% | 160.59% |
| Capital Expenditure | -160.32% | 84.05% | -106.81% | 33.22% | -105.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.61% | -1.59% | 101.06% | -395.61% | -- |
| Cash from Investing | -10,200.00% | 99.70% | 94.57% | -455.97% | 1,335.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 38.04% | -1.17% | -0.59% | -147.10% | 63.87% |
| Issuance of Common Stock | -- | -- | 4.35% | 64.78% | 293.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.23% | 33.23% | 33.09% | -- | -- |
| Cash from Financing | 16.99% | -128.04% | 20.71% | 12.01% | 1,060.11% |
| Foreign Exchange rate Adjustments | -- | -- | 0.00% | 66.67% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.54% | -228.49% | 599.79% | -90.90% | 323.02% |